SCHEMBL7043883

SCHEMBL7043883

Cc1ccc(C(N)=O)cc1[AsH2]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 7/20 0.50
▸ MAPT P10636 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ LCK P06239 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ BRD4 O60885 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ BRPF1 P55201 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PRSS1 P07477 1/20 0.42
▸ PRSS2 P07478 1/20 0.42
▸ PRSS3 P35030 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ PARP10 Q53GL7 1/20 0.42
▸ PARP2 Q9UGN5 1/20 0.42
▸ PARP4 Q9UKK3 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ BRD9 Q9H8M2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29503140 0.82 PRSS1 (0.61) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1002832 0.82 PRSS1 (0.61) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL6825758 0.78 PARP1 (0.50) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1805869 0.78 PARP1 (0.50) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL284729 0.78 TDP1 (0.73) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1805871 0.78 LCK (0.53) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1804065 0.77 PARP1 (0.48) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1755245 0.77 HPGD (0.51) PARP1MAPTALDH1A1
SCHEMBL29506358 0.77 MTOR (0.49) PARP1MAPTTDP1LCKALDH1A1
SCHEMBL1233265 0.77 MTOR (0.49) PARP1MAPTTDP1LCKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409463-A1 N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION Bristol-Myers Squibb Company (US) 2004-04-21 — — EP disclosed
WO-2003002542-A1 N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-01-09 — — WO disclosed
Send feedback